Search Medical Condition
Please enter condition
Please choose location from dropdown

Daqing, China Clinical Trials

A listing of Daqing, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (8) clinical trials

A Safety and Efficacy Study of Dissolve in Treatment of Coronary In-stent Restenosis

The purpose of this study is to evaluate the efficacy and safety of treatment of coronary in-stent restenosis by Paclitaxel-eluting balloon catheter Dissolve versus SeQuentPlease, and the reference diameter of coronary artery stenosis is 2.5mm-4.0mm and the length 26mm.

Phase N/A

0.0 miles

Learn More »

A Safety and Efficacy Study of Dissolve in Treatment of Coronary Small Vessel Disease

The purpose of this study is to evaluate the efficacy and safety in the treatment of Coronary Small Vessel Disease by drug coated balloon (DCB) Dissolve versus drug eluting stent (DES) Resolute Integrity.

Phase N/A

0.0 miles

Learn More »

Chinese Herbal Medicine and Micronized Progesterone for Threatened Miscarriage RCT

The causes of spontaneous miscarriage are diverse and comprise chromosomal, genetic, anatomical, immunological, hormonal, infectious and psychological factors, the other factors contribute to an increased risk include advancing paternal and maternal age and mothers with systemic diseases, such as diabetes or thyroid dysfunction. However, the incidence is difficult to determine ...

Phase

0.0 miles

Learn More »

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death

Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events

Phase

0.09 miles

Learn More »

Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.

This is an international, multicentre, parallel-group, event-driven, randomised, double-blind study in patients with HFpEF, evaluating the effect of dapagliflozin 10 mg versus placebo, given once daily in addition to background regional standard of care therapy, including treatments to control co-morbidities, in reducing the composite of CV death and heart failure ...

Phase

0.09 miles

Learn More »

Effect of Intravenous Metoprolol Combining RIPC on Myocardial Protection in STEMI Patients

This study is a multicenter randomized controlled clinical trial, and planning to enroll 1200 patients with anterior STEMI. At the first medical contactpatients who meet the inclusion/exclusion criteria are divided into different groups before reperfusion. Patients randomize into placbo, Metoprolol, RIPC and Metorolol+RIPC groups. Subsequently, the investigator conduct diagnosis and ...

Phase

4.31 miles

Learn More »

OCT Registry in Patients With STEMI During PPCI

This is a prospective, multi-center, non-randomized, observational registry study of STEMI patients that require primary catheterization.The purpose of this registry is to investigate the clinical outcomes, safety and cost-effectiveness of intravascular OCT imaging in patients with STEMI undergoing primary PCI.The total duration of the study is expected to be 5 ...

Phase N/A

4.31 miles

Learn More »

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patients were divided into two groups(optimized group and un-optimized group) according to treatment models they accepted in 20 reginally representative hosptials of China. whether optimizaed or ...

Phase N/A

4.31 miles

Learn More »